The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Novartis; Pfizer; Roche
Speakers' Bureau - Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Novartis; Pfizer; Roche
Ribociclib (RIB) + fulvestrant (FUL) in postmenopausal women with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC): Results from MONALEESA-3.
 
Dennis J. Slamon
Leadership - Biomarin
Stock and Other Ownership Interests - Pfizer
Honoraria - Novartis
Consulting or Advisory Role - Lilly; Novartis
Research Funding - Novartis; Pfizer
Travel, Accommodations, Expenses - Biomarin; Novartis; Pfizer
 
Patrick Neven
No Relationships to Disclose
 
Stephen K. L. Chia
Honoraria - Genomic Health; Novartis
Consulting or Advisory Role - Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Genentech (Inst); Genomic Health (Inst); Novartis (Inst); Roche (Inst)
 
Seock-Ah Im
Consulting or Advisory Role - AstraZeneca; Hanmi; Novartis; Pfizer; Roche
Research Funding - AstraZeneca
 
Peter A. Fasching
Honoraria - Amgen; Celgene; Novartis; Pfizer; Roche
Research Funding - Novartis (Inst)
 
Michelino DeLaurentiis
Honoraria - AstraZeneca; Celgene; Eisai; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Pfizer; Roche
Research Funding - AstraZeneca; Novartis; Roche
 
Katarina Petrakova
No Relationships to Disclose
 
Giulia Valeria Bianchi
No Relationships to Disclose
 
Francisco J. Esteva
Consulting or Advisory Role - AstraZeneca; Celgene; Celltrion; Genentech/Roche; Glenmark; NanoString Technologies; Novartis; Puma Biotechnology; Seagen
Research Funding - Genentech/Roche (Inst); Kadmon (Inst); Merrimack (Inst); Novartis (Inst); Synta (Inst)
Patents, Royalties, Other Intellectual Property - Myriad Genetics (royalties)
Travel, Accommodations, Expenses - Novartis
 
Miguel Martin
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Roche/Genentech
Research Funding - Novartis (Inst); Roche (Inst)
 
Xavier Pivot
No Relationships to Disclose
 
Gena Vidam
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Yingbo Wang
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Cristina Karen Rodriguez Lorenc
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Michelle Kristine Miller
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Tanya Taran
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Guy Heinrich Maria Jerusalem
Honoraria - Amgen; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Lilly; Novartis; Pfizer; Puma Biotechnology; Roche
Research Funding - Novartis; Roche
Travel, Accommodations, Expenses - Lilly; Novartis; Pfizer; Roche